statistiche ricercatore

Continente	#
NA - Nord America	1.559
AS - Asia	931
EU - Europa	897
SA - Sud America	117
AF - Africa	35
OC - Oceania	10
Continente sconosciuto - Info sul continente non disponibili	2
Totale	3.551

Nazione	#
US - Stati Uniti d'America	1.500
IT - Italia	334
SG - Singapore	269
VN - Vietnam	227
CN - Cina	148
DE - Germania	115
RU - Federazione Russa	106
BR - Brasile	89
HK - Hong Kong	85
GB - Regno Unito	71
IN - India	66
CA - Canada	46
FR - Francia	45
SE - Svezia	44
BD - Bangladesh	39
IE - Irlanda	35
FI - Finlandia	23
ES - Italia	20
HU - Ungheria	16
PL - Polonia	13
DK - Danimarca	12
NL - Olanda	12
UA - Ucraina	12
RO - Romania	11
TR - Turchia	11
AU - Australia	10
ET - Etiopia	10
ID - Indonesia	10
IQ - Iraq	10
KR - Corea	10
AR - Argentina	8
JP - Giappone	8
MX - Messico	8
MY - Malesia	8
ZA - Sudafrica	8
EG - Egitto	7
AT - Austria	6
CL - Cile	6
IR - Iran	5
PH - Filippine	5
PK - Pakistan	5
SA - Arabia Saudita	5
AE - Emirati Arabi Uniti	4
CO - Colombia	4
EC - Ecuador	4
GE - Georgia	4
VE - Venezuela	4
BA - Bosnia-Erzegovina	3
BE - Belgio	3
CH - Svizzera	3
NG - Nigeria	3
TH - Thailandia	3
UZ - Uzbekistan	3
AL - Albania	2
BG - Bulgaria	2
DZ - Algeria	2
JO - Giordania	2
KE - Kenya	2
LT - Lituania	2
MA - Marocco	2
MD - Moldavia	2
PY - Paraguay	2
RS - Serbia	2
BY - Bielorussia	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
EU - Europa	1
JM - Giamaica	1
KG - Kirghizistan	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PT - Portogallo	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.551

Nome	#
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes	455
Effect of the ketogenic diet in excitable tissues	443
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease	430
Channelopathies and epileptic syndromes: characterization of novel variants associated with progressive epileptic encephalopathy and in vitro validation of therapeutic approaches	404
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy	379
Progressive epileptic encephalopathy associated with a novel HCN2 mutation	370
Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations	341
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet	316
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020)	300
HCN1 novel mutations in familiar generalized epilepsy	268
Totale	3.706

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	41	0	0	0	0	0	0	0	0	0	0	0	41
2021/2022	197	33	38	30	21	6	9	11	12	5	7	4	21
2022/2023	249	22	80	29	19	21	36	4	9	18	3	4	4
2023/2024	270	4	11	8	27	46	55	18	23	25	12	5	36
2024/2025	567	34	60	39	24	52	29	29	30	57	91	48	74
2025/2026	1.583	244	65	98	221	188	88	208	58	125	95	70	123
Totale													3.706

Bicocca Open Archive